$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
How effective is ensifentrine-Ohtuvayre in treating COPD?
2026-02-01 22:25:32
Check Details
Definition of properties of everolimus/Afinitor targeted drugs
2026-02-01 22:25:32
Check Details
How much does it cost to take Anagrelide for a year?
2026-02-01 22:25:32
Check Details
Introduction to the properties and uses of the drug Atrasentan
2026-02-01 22:25:32
Check Details
Elotuzumab specifications and parameters
2026-02-01 22:25:32
Check Details
Bimekizumab instructions and medication precautions
2026-02-01 22:25:32
Check Details
Why doctors don't recommend long-term use of ensifentrine - Ohtuvayre
2026-02-01 22:25:32
Check Details
Comparison of the differences between everolimus/Afinitor and sirolimus
2026-02-01 22:25:32
Check Details
Can I stop taking Anagrelide once I start taking it?
2026-02-01 22:25:32
Check Details
Different versions of Atrasentan and selection recommendations
2026-02-01 22:25:32
Check Details
Latest clinical developments of Elotuzumab
2026-02-01 22:25:32
Check Details
What are the main indications for bimekizumab?
2026-02-01 22:25:32
Check Details
1
2
...
2246
2247
2248
2249
2250
2251
2252
...
10213
10214
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Plerixafor: Mobilizing Hematopoietic Stem Cells for Autologous Transplantation
2
Brensoctib: Managing Side Effects of the Novel DPP-1 Inhibitor for Bronchiectasis
3
Tivozanib: The Evolution of Highly Selective VEGFR Inhibition in Renal Cell Carcinoma
4
Trifluridine/Tipiracil: Managing Side Effects in Metastatic Colorectal and Gastric Cancer
5
Trelagliptin: The First Once-Weekly DPP-4 Inhibitor Revolutionizing Type 2 Diabetes Care
6
Adagrasib Medication Management Guide for Special Populations
7
Olutasidenib (Rezlidhia): A Targeted Drug for IDH1-Mutated Relapsed/Refractory AML
8
Capmatinib Redefines Precision Therapy for MET-Mutated Lung Cancer
9
FDA Approves Dual Immunotherapy Combo: Tecvayli + Darzalex Faspro Transforms RRMM Treatment
10
Cabozantinib: Pivotal Advancements and Global Implications in Multi-Cancer Treatment with Multi-Kinase Inhibition
11
Pretomanid for Drug-Resistant TB: Risks and Management of 3-Year Treatment
12
SKYSCRAPER-02C Study: New Hope for Extensive-Stage Small Cell Lung Cancer Treatment